Preotact 100 micrograms powder and solvent for solution for injection
Parathyroid hormone
Read all of this leaflet carefully before you start using this medicine.
- Keep this leaflet. You may need to read it again.
- If you have any further questions, ask your doctor or your pharmacist.
- This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same
as yours. - If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your
doctor or pharmacist.
In this leaflet:
- 1. What Preotact is and what it is used for
- 2. Before you use Preotact
- 3. How to use Preotact
- 4. Possible side effects
- 5 How to store Preotact
- 6. Further information
What Preotact Is And What It Is Used For
Preotact is used to treat osteoporosis in women past menopause with high risk of fractures.
Osteoporosis is a disease that causes bones to become thin and fragile. It is especially common in women after the menopause. The
disease progresses gradually so you may not feel any symptoms at first. But if you have osteoporosis, it makes you more likely to break
bones, especially in your spine, hips and wrists. It may also cause back pain, loss of height, and a curved back.
Preotact reduces the risk of breaking spinal bones because it increases your bone quality and strength.
Before You Use Preotact
Do not use Preotact:
- if you are allergic (hypersensitive) to parathyroid hormone or any of the other ingredients of Preotact;
- if you have had radiation therapy to the skeleton;
- if you suffer from high calcium levels and other disturbances in the calcium-phosphor metabolism;
- if you have other bone disease (including hyperparathyroidism or Paget’s disease);
- if you have high levels of alkaline phosphatase;
- if you suffer from severe kidney problems;
- if you suffer from severe liver disease;
Measuring of the calcium levels in the blood and/or urine
Your doctor will check your response to treatment at regular intervals. He or she must perform blood and/or urine tests at month 1,
3 and 6 after starting your treatment with Preotact.
Take special care with Preotact:
Preotact should be used with caution if you suffer from kidney stones or have had kidney stones.
Specific populations:
Children and adolescents
Preotact should not be used in children or adolescents.
Elderly
No special precautions.
Taking other medicines:
Please inform your doctor or pharmacist if you are taking or have recently taken any other medicines, even those not prescribed.
Preotact should be used with caution if you receive heart medicine.
Taking Preotact with food and drink
Food and drink have no influence on the effect of Preotact.
Pregnancy and breast-feeding
Do not use Preotact if you are pregnant or breast-feeding.
Driving and using machines:
No studies on the ability to drive or operate machines have been performed. If you feel dizzy, do not drive or operate any machines
until you feel better.
Important information about some of the ingredients of Preotact:
This medicinal product contains less than 1 mmol sodium (23 mg) per dose. This means that it is essentially “sodium-free”.
How To Use Preotact
Always use Preotact exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.
Dosage
The usual dose of Preotact is 100 micrograms given once a day.
Your doctor may advise you to take supplementary calcium and vitamin D. Your doctor will tell you how much you should take each
day.
Method of administration
Preotact should be used with the Preotact pen.
When you place the cartridge in the Preotact pen, the solvent and the powder mix. The solution is then ready to be injected into the
abdomen (under the skin). When not in use put the Preotact pen into the refrigerator.
Important information when using Preotact
- Inject yourself with Preotact shortly after you have taken the Preotact pen out of the refrigerator
- Put the Preotact pen back into the refrigerator immediately after you have used it. Never remove a cartridge in use from the
pen.
DO NOT SHAKE the Preotact pen (neither before nor after injection) as it may destroy the effect of the active
substance- Use a new injection needle for each injection and throw it away after each use.
- Never store your Preotact pen with the needle attached.
- Never share your Preotact pen with anyone.
For instructions on how to use the Preotact pen, please read the User Manual of the Preotact pen.
Duration of treatment
Keep using Preotact for as long as your doctor prescribes it for you – normally no longer than 24 months.
If you use more Preotact than you should:
If, by accident, you inject more than one dose of Preotact in a day, contact your doctor or pharmacist.
If you forget to use Preotact:
If you forget to take Preotact (or cannot take Preotact at your usual time), take it as soon as possible on that day. Never take
more than one injection in the same day. Do not take a double dose to make up for forgotten doses.
If you stop taking Preotact:
If you stop taking Preotact before finishing the treatment please inform you doctor.
Preotact Side Effects
Like all medicines, Preotact can cause side effects, although not everybody gets them.
The most common side effects (in more than 10% of patients) are: increased level of calcium in the blood, increased level of
calcium in the urine, and nausea.
Common side effects (in 1 to 10% of patients) are: back pain, constipation, decreased muscle strength, diarrhoea, dizziness,
erythema at injection site, fast or irregular heart beats, headache, muscle cramps, pain in extremity, stomach upset, tiredness, and
vomiting.
Uncommon side effects (in 0.1% to 1% of patients) are: abdominal pain, flu, increased level of uric acid in the blood,
irritation of the skin at the injection site, loss of appetite, smell disturbance, and taste disturbance.
If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or
pharmacist.
How To Store Preotact
Keep out of the reach and sight of children.
Do not use Preotact after the expiry date which is stated on the cartridge after EXP and on the carton after EXP. The expiry date
refers to the last day of that month.
Unused cartridge
- Do not store above 25°C. Do not freeze.
- Keep the cartridges in the outer carton in order to protect them from light
Cartridge in use
- A cartridge in use (in the Preotact pen) should be stored in a refrigerator (2-8°C).
Do not freeze. - A cartridge in use will keep for 28 days in refrigerator.
- If for some reason you cannot store your Preotact pen (with the inserted cartridge) in a refrigerator for a number of days,
it can be stored outside the refrigerator below 25°C - BUT ONLY FOR A TOTAL OF 7 DAYS during the 28-day use period. - If the Preotact solution in the cartridge is more than 28 days old, or if it has not been stored correctly, throw it away,
even if the cartridge is not completely empty. - If the Preotact solution becomes cloudy or coloured throw the cartridge away.
Any unused product or waste material should be disposed of in accordance with local requirements.
Further Information
What Preotact contains
Preotact is supplied in a dual-chamber cartridge. The first chamber contains the powder with the active substance and the second
chamber contains the solvent.
- The active substance is parathyroid hormone. Each cartridge contains 1.61 mg parathyroid hormone. When the powder and the
solvent have been mixed, the solution for injection contains parathyroid hormone at a concentration of 1.4 mg/ml. - Other ingredients: The powder contains sodium chloride 0.4 %, mannitol, citric acid monohydrate, hydrochloric acid, and
sodium hydroxide. The solvent contains metacresol and water for injections.
What Preotact looks like and contents of the pack
Preotact is a powder and solvent for solution for injection.
It is supplied in a dual-chamber cartridge which contains 1.61 mg parathyroid hormone as powder and 1.13 ml of solvent
Preotact is available in packs of 2 and 6 cartridges. Not all pack sizes may be marketed.
Marketing Authorisation Holder and Manufacturer
Tlf: +45 46 77 11 11
info@nycomed.com
For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder.
United Kingdom
This leaflet was last approved in April 2009.
Detailed information on this medicine is available on the European Medicines Agency (EMEA) web site:
http://www.emea.eu.int/
No comments:
Post a Comment